TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
11,798
|
12,674
|
10,611 |
| Financial expenses |
35
|
43
|
42 |
| Earnings before taxes |
355
|
2,149
|
1,867 |
| EBITDA |
904
|
2,433
|
2,338 |
| Total assets |
12,939
|
12,845
|
10,955 |
| Current assets |
5,084
|
4,541
|
3,269 |
| Current liabilities |
2,807
|
2,656
|
2,512 |
| Equity capital |
10,043
|
10,097
|
8,369 |
| - share capital |
2,314
|
2,396
|
2,389 |
| Employees (average) |
22
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
78.6%
|
76.4% |
| Turnover per employee |
536
|
528
|
505 |
| Profit as a percentage of turnover |
3.0%
|
17.0%
|
17.6% |
| Return on assets (ROA) |
3.0%
|
17.1%
|
17.4% |
| Current ratio |
181.1%
|
171.0%
|
130.1% |
| Return on equity (ROE) |
3.5%
|
21.3%
|
22.3% |
| Change turnover |
-445
|
2,032
|
1,002 |
| Change turnover % |
-4%
|
19%
|
10% |
| Chg. No. of employees |
-2
|
3
|
-2 |
| Chg. No. of employees % |
-8%
|
14%
|
-9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.